NEWARK – The Board of Pharmacy has proposed a regulation, N.J.A.C. 13:39-1.9, to require each pharmacy permit holder and registered pharmacist-in-charge to implement a continuous quality improvement program (CQI) to detect, identify, and prevent prescription errors. The primary purpose of the CQI is to advance error prevention by analyzing, individually and collectively, investigative and other pertinent data collected in response to a prescription error. The proposed new rule requires creation and implementation of a process to investigate the cause of errors and address them, so as to improve the process proactively, avoid future system and process failures, and enhance patient safety.

The proposed regulation, and information on how to submit a comment by November, 19, 2021 can be viewed here.

###